Nomura Securities Starts Synageva BioPharma (GEVA) at Buy, $85 PT
Tweet Send to a Friend
Nomura Securities initiates coverage on Synageva BioPharma (NASDAQ: GEVA) with a Buy. PT $85.00.
Analyst Ian Somaiya comments: "Synageva ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst Ian Somaiya comments: "Synageva ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
